This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $17,968.39, is for the delivery of the drug WELIREG 40 MG TABLET 90S. It is a Firm Fixed Price delivery order contract that runs through December 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC, a large pharmaceutical distribution company that is a subsidiary of AmerisourceBergen Corporation. The contract is for the emergency procurement of 40mg tablets of the cancer drug Welireg (belzutifan) with a ceiling value of $59,277.03 and a period of performance ending on August 1, 2022. ASD Specialty...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the provision of a wide range of prescription medications, over-the-counter drugs, and medical supplies to various U.S. government agencies. The contract, valued at $15,821.79, is a Firm Fixed Price Delivery Order with an ultimate completion date of July 2, 2024. It was awarded by the Department of Defense's (DOD) Medical Supply Chain,...
This federal contract award is a delivery order with a firm fixed price of $5,624.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract was awarded by the Medical Supply Chain of the U.S. Department of Defense (DoD) and has a period of performance through May 6, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, the prime contractor, is a major supplier of pharmaceuticals...
This federal contract award, valued at $61,313.28, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of July 9, 2024. Amerisourcebergen, through its Corporate Office division, will be providing a variety of pharmaceutical products and medical supplies to support federal government healthcare programs. The contract is...
This federal contract award, valued at $32,443.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $34,673.60, was issued by the Medical Supply Chain division of the U.S. Department of Defense (DoD) to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order contract has a firm fixed price pricing type and an ultimate completion date of July 16, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, is providing a wide range of medical products and prescription medications to support DoD and other...
This federal contract award, valued at $25,558.25, was issued by the Medical Supply Chain division of the Defense agency to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of April 16, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a subsidiary of parent company Cencora, Inc., has extensive experience...
This federal contract award, valued at $25,195.56, was issued by the Medical Supply Chain division of the U.S. Department of Defense (DoD) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order with a firm fixed-price pricing type, and has an ultimate completion date of April 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of prescription medications, over-the-counter drugs, and medical supplies to support DoD...
This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $6,934.20 Firm Fixed Price Delivery Order contract was awarded by the Medical Supply Chain division of the Department of Defense (DoD) on July 8, 2024, with a completion date of July 9, 2024. The contract does not have a set-aside designation and is for the provision of pharmaceutical products and medical...